Literature DB >> 7784134

Surfactant protein-B supplementation improves in vivo function of a modified natural surfactant.

K Mizuno1, M Ikegami, C M Chen, T Ueda, A H Jobe.   

Abstract

The effect of the addition of surfactant protein (SP)-B or SP-B plus SP-C (SP-BC) to a surfactant made from bovine lung (Survanta) was evaluated in 27-d-gestation preterm rabbits. The animals were treated with Survanta, Survanta + 2% SP-B, Survanta + 3% SP-BC, or sheep surfactant. They were then ventilated with 3 cm H2O positive end-expiratory pressure and tidal volumes of 8 mL/kg. Survanta + 2% SP-B was prepared by adding SP-B in water to Survanta or by adding SP-B in chloroform [SP-B(Chl)] to lipid-extracted Survanta. Dynamic compliances of the Survanta + 2% SP-B(Chl)- and Survanta + 3% SP-BC-treated rabbits were greater (p < 0.05) than those treated with Survanta or Survanta + 2% SP-B in water and were comparable to sheep surfactant. Postventilation pressure-volume curves for the groups treated with Survanta supplemented with SP-B had significantly larger retained volumes on deflation compared with those treated only with Survanta (p < 0.01). The effects of ventilation style on the responses were assessed by ventilating other groups of rabbits treated with Survanta, Survanta + 0.5% SP-B(Chl), Survanta + 2% SP-B(Chl), or sheep surfactant with tidal volumes of 10 mL/kg and 0 cm H2O positive end-expiratory pressure. SP-B (2%) augmented the in vivo function of Survanta without positive end-expiratory pressure, and 0.5% SP-B had no effect. Infasurf, a surfactant with more SP-B, was more effective than Survanta when tested in the preterm rabbits. SP-B is a critical factor for optimum immediate surfactant function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784134     DOI: 10.1203/00006450-199503000-00004

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  16 in total

1.  A concentration-dependent mechanism by which serum albumin inactivates replacement lung surfactants.

Authors:  H E Warriner; J Ding; A J Waring; J A Zasadzinski
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

2.  Surface film formation in vitro by infant and therapeutic surfactants: role of surfactant protein B.

Authors:  Olivier Danhaive; Cheryl Chapin; Hart Horneman; Paola E Cogo; Philip L Ballard
Journal:  Pediatr Res       Date:  2014-10-31       Impact factor: 3.756

3.  More than a monolayer: relating lung surfactant structure and mechanics to composition.

Authors:  Coralie Alonso; Tim Alig; Joonsung Yoon; Frank Bringezu; Heidi Warriner; Joseph A Zasadzinski
Journal:  Biophys J       Date:  2004-09-28       Impact factor: 4.033

4.  Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability.

Authors:  J Ding; D Y Takamoto; A von Nahmen; M M Lipp; K Y Lee; A J Waring; J A Zasadzinski
Journal:  Biophys J       Date:  2001-05       Impact factor: 4.033

5.  A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.

Authors:  H Walti; M Monset-Couchard
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

6.  Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.

Authors:  R Duncan Hite; Bonnie L Grier; B Moseley Waite; Ruud A Veldhuizen; Fred Possmayer; Li-Juan Yao; Michael C Seeds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-28       Impact factor: 5.464

Review 7.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

8.  Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.

Authors:  Georgios Baroutis; Joseph Kaleyias; Theodora Liarou; Eugenia Papathoma; Zoe Hatzistamatiou; Christos Costalos
Journal:  Eur J Pediatr       Date:  2003-04-23       Impact factor: 3.183

9.  Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period.

Authors:  P Rauprich; O Möller; G Walter; E Herting; B Robertson
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

10.  Cognitive, educational, and behavioural outcomes at 7 to 8 years in a national very low birthweight cohort.

Authors:  L J Horwood; N Mogridge; B A Darlow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-07       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.